The Thumbay Research Institute for Precision Medicine (TRIPM), Gulf Medical University, welcomed Dr. Mohammad A. Qasaimeh from New York University Abu Dhabi for an invited faculty talk titled “Tiny Technologies, Big Impact: Microfluidics Transforming Modern Medicine.” The session highlighted how microfluidic technologies are transforming biomedical research, diagnostics, disease modeling, and next-generation healthcare solutions.
Dr. Qasaimeh shared recent advances from the Advanced Microfluidics and Microdevices Laboratory (AMMLab), focusing on the development of miniaturized biomedical systems that support discovery science, translational diagnostics, and precision healthcare applications. His talk emphasized the growing role of engineering-driven microfluidic platforms in enabling more precise biological analysis and accelerating translational biomedical innovation.
During the lecture, Dr. Qasaimeh discussed microfluidic platforms designed to precisely control cellular microenvironments and enable quantitative single-cell analysis. These technologies provide new insights into how mechanical and biochemical signals regulate cellular behavior and contribute to disease progression. He also highlighted translational diagnostic applications, including microfluidic systems for circulating tumor cell mechano-phenotyping and rapid paper-based platforms for molecular and serological detection.
The talk further covered scalable strategies for engineering and cryopreserving three-dimensional tumor models for drug screening and cancer research. In addition, Dr. Qasaimeh introduced emerging biomedical sensing technologies, including soft microfluidic tactile sensors designed to restore haptic feedback in minimally invasive surgical tools.
Following the session, Dr. Qasaimeh engaged in further discussions with TRIPM faculty members on how such engineering technologies could be adapted and integrated in two complementary directions: first, to support proof-of-concept studies that bridge engineering innovation with biomedical discovery; and second, to advance the application of these technologies in precision oncology, particularly in cancer diagnostics, tumor modeling, drug screening, and translational research.
Through this invited faculty talk, TRIPM reinforced its commitment to advancing precision medicine by engaging with leading researchers whose work connects engineering, cancer biology, translational diagnostics, and deployable healthcare technologies. The session provided faculty members, researchers, and students with valuable insights into how microfluidic innovation can contribute to the future of modern medicine and precision oncology.
Aligned with the United Nations Sustainable Development Goals (SDGs):
SDG 4: Quality Education; SDG 17: Partnerships for the Goals
